SSY Group Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares SSY Group Ltd with three other
companies in this sector in China:
Shanghai Dingli Technology Development (Group) Co.Ltd
sales of 1.71 billion Chinese Renmimbi [US$253.08 million]
of which 83%
Zhangzhou Pientzehuang Pharmaceutical Company Ltd
(1.88 billion Chinese Renmimbi [US$278.18 million]
Mayinglong Pharmaceutical Group Co Ltd
(1.78 billion Chinese Renmimbi [US$263.13 million]
of which 47%
was Pharmaceutical Circulation).
SSY Group Ltd reported sales of 1.80 billion Chinese Renmimbi (US$266.03 million)
December of 2015.
increase of 8.3%
versus 2014, when the company's sales were 1.66 billion Chinese Renmimbi.
Despite this increase, sales are still
below the level achieved in 2013, when SSY Group Ltd
reported sales of 2.17 billion Chinese Renmimbi.
The sales level in 2015 was fairly close to the level five years ago: in 2010, SSY Group Ltd had sales
of 1.72 billion Chinese Renmimbi.